Codes ATC:
C05AA09
EMLc
Indication
Palliative care
Code ICD11:
QC7A
INN
Dexamethasone
Type de médicament
Chemical agent
Type de liste
Liste de base
(EML)
(EMLc)
(EMLc)
Formulations
Oral > Liquid:
2 mg per 5 mL (as sodium phosphate) ;
0.5 mg per 5 mL (as sodium phosphate)
(EMLc)
Parenteral > General injections > unspecified: 4 mg per mL in 1 mL ampoule (dexamethasone phosphate (as sodium phosphate) equialent to 3.3 mg dexamethasone base)
Oral > Solid > tablet: 2 mg (as dexamethasone base) ; 4 mg (as dexamethasone base) ; 0.5 mg (as dexamethasone base) ; 0.75 mg (as dexamethasone base) ; 1.5 mg (as dexamethasone base)
Parenteral > General injections > unspecified: 4 mg per mL in 1 mL ampoule (dexamethasone phosphate (as sodium phosphate) equialent to 3.3 mg dexamethasone base)
Oral > Solid > tablet: 2 mg (as dexamethasone base) ; 4 mg (as dexamethasone base) ; 0.5 mg (as dexamethasone base) ; 0.75 mg (as dexamethasone base) ; 1.5 mg (as dexamethasone base)
Historique des statuts LME
Sexe
Tous
Âge
Aussi recommandé pour les enfants
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite
sur les brevets.
Wikipédia
DrugBank
Résumé des preuves et recommandation du comité d'experts
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended:
- the addition of dexamethasone oral liquid 0.5 mg/5 mL (as sodium phosphate) to the EMLc;
- the addition of dexamethasone tablets 0.5 mg, 0.75 mg, 1.5 mg and 4 mg (as dexamethasone base) to the EML and EMLc;
- to modify the listings to reflect the amount of dexamethasone in terms of dexamethasone salt or dexamethasone base.